focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: NHS Uses Induction Healthcare's Mobile App

Thu, 16th Apr 2020 14:57

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and late Wednesday and not separately reported by Alliance News:

----------

Induction Healthcare Group PLC - healthcare technology - Says majority of doctors in UK National Health Service using Induction healthcare information mobile application. Says demand for company's tools have increased as a result of Covid-19 outbreak.

----------

N4 Pharma PLC - pharmaceuticals - Receives Covid-19 plasmid DNA from National Institute for Health in US. Researching whether Nuvec medication can produce Covid-19 antibodies.

----------

Target Healthcare REIT PLC - healthcare property investor - Received rent collection for March quarter in line with usual collection patterns. Says confirmed Covid-19 cases affecting fewer than 5% of beds in its portfolio.

----------

Two Shields Investments PLC - investor - Portfolio company BrandShield warns of increase in phishing scams during the pandemic. Warns that illicit scams target users of streaming services, 639 new domain names with the word Netflix were registered since beginning of 2020.

----------

Morses Club PLC - lender - Launches remote lending product. Says 33% of collections transferred from face-to-face to remote over past three weeks.

----------

Charles Stanley Group PLC - wealth manager - Funds under management down 20% to GBP20.2 billion in three months to March from GBP25.3 billion in December amid market volatility.

----------

Management Consulting Group PLC - consultants - Says 2020 started promisingly but trading began to suffer in Asia in February due to pandemic. Disruption spread to other regions in March. Targeting, unconnected to Covid-19, GBP4 million in annual cost savings.

----------

Dillistone Group PLC - recruitment software - Had "strong" start to 2020 prior to Covid-19 impact. Says demand suffered due to pandemic. Says no full-year guidance and delays annual results, initially penned to be reported on April 27.

----------

Gaming Realms PLC - mobile games - Delays full-year results that were initially planned for this week. Audit yet to be completed due to Covid-19 disruption.

----------

Sportech PLC - gambling software - Delays annual general meeting due to Covid-19. AGM to be held before end of June, but not on May 20 as initially planned. Chair and chief executive officer take 50% pay cuts, salary freeze implemented, and "significant" number of staff furloughed.

----------

Escape Hunt PLC - escape room experiences - Has furloughed 124 staff and expects VAT and other tax deferrals. Says some landlords have allowed for rent payments to be deferred and senior staff have taken 25% pay cut. Company's monthly cash costs slashed by 70%.

----------

Revolution Bars Group PLC - bar operator - Increases Natwest revolving credit facility to GBP30.0 million until August 31.

----------

Hornby PLC - toys and hobby products - Benefiting from government support schemes in markets where it operates. Says full-year revenue and gross margin ahead of year prior but no financial guidance of Covid-19 impact due to uncertainty.

----------

Walker Greenbank PLC - interior furnishings - Closed factories in UK as well as showrooms elsewhere in New York and Paris. Accessing government support schemes "wherever possible". Vast majority of employees furloughed and management team take 20% salary reduction.

----------

Haydale Graphene Industries PLC - advanced materials - Still assessing full impact of virus but notes falling demand for silicon carbide blanks. Taking advantage of US and UK government support schemes.

----------

Woodbois Ltd - forestry and timber - Says first quarter revenue up 10% year-on-year amid no Covid-19 demand hit until end of quarter. Factories in Gabon closed due to lockdown.

----------

DX Group PLC - freight and delivery - Says delivery activity down by 33% immediately after UK government lockdown. Furloughs some employees and has cut spending.

----------

Volex PLC - power products - Sales for the year ended April 5 up 5.4% to USD392 million from USD372 million. Expects future trading to be hit by government containment measures due to Covid-19.

----------

Proton Motor Power Systems PLC - fuel cell technology - No case of Covid-19 at factories. Protective measures in place at Puchheim, Munich unit.

----------

Amedeo Air Four Plus Ltd - aircraft leasing - Customer Emirates seeking financial accommodation. Amedeo asks asset manager to continue talks with the airline and its lending banks.

----------

TP Group PLC - engineering services - To build gas production equipment in response to Covid-19. Says equipment will be able to produce medical gases.

----------

Kodal Minerals PLC - exploration and development - Granted renewal of exploration permits at Dabakala and Korhogo gold projects in Cote d'Ivoire. Notes planned activity at joint-venture projects with Resolute Mining Ltd postponed due to virus.

----------

SolGold PLC - gold and copper miner - Receives expressions of interest for potential concentrate offtake at Alapala project, Ecuador. Says 10 received and more expected when Covid-19 restrcitions lifted.

----------

Hummingbird Resources PLC - gold miner - No material production hit from Covid-19 but risk mitigation measures in place. First quarter production down 11% quarter-on-quarter to 30,282 ounces of gold poured.

----------

Capital Drilling Ltd - mining services - Says mining operations continue uninterrupted despite Covid-19 uncertainty. Supply chain movement mainly land and sea based so largely unaffected by travel curbs. First-quarter revenue rises 20% to USD32.5 million.

----------

Base Resources Ltd - mineral explorers - Says operations at Kwale, Kenya continued uninterrupted so full-year guidance maintained. In quarter-ended March, ilmenite production up 20% year-on-year, rutile up 17% and zircon rises 32%.

----------

Reabold Resources PLC - oil project investor - Drilling at IMIC-2 well in 50%-owned Danube project, Romania delayed due to Covid-19 border closures. Reports commencement of activity at West Newton B site onshore UK.

----------

Tlou Energy Ltd - gas and solar projects - Says cost reductions in place to counter Covid-19 impact. Notes state of national emergency declared in Botswana.

----------

Great Western Mining Corp PLC - explorer - Application for surface disturbance works at Nevada acreage accepted in "timely manner" despite Covid-19 outbreak.

----------

Anglo Asian Mining PLC - gold, silver and copper producer - Reports 10% first quarter fall in gold equivalent production to 18,219 ounces. Says first quarter in line with guidance despite Covid-19 outbreak.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 11:56

N4 Pharma strikes partnership deal for intracellular delivery

(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc.

Read more
23 Apr 2024 13:32

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to no revenue a year ago. Pretax loss widens to GBP1.4 million from GBP1.2 million. Looks ahead to the rest of 2024 with "great optimism."

Read more
18 Apr 2024 12:14

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.

Read more
15 Feb 2024 13:17

N4 Pharma shares jump on latest Nuvec developments

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.

Read more
15 Feb 2024 12:06

IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - Reports an "encouraging" update from its Nuvec delivery system for cancer treatments, gene therapy and vaccines. It has completed in-vitro experiments combining epidermal growth factor receptor and polo like kinase 1 molecules onto a Nuvec nanoparticle, before testing it on lung cancer cells. "The work clearly shows that there is a strong beneficial effect at 48 hours on cellular inhibition compared to single dose siRNA, by combining both EGFR and PLK1 onto the same particle," N4 says.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
19 Jan 2024 13:00

N4 Pharma's Nuvec granted patent in India

(Sharecast News) - N4 Pharma, a pharmaceutical company developing the cancer vaccine delivery system Nuvec, announced on Friday that it has received confirmation from the University of Queensland regarding the granting of its patent for Nuvec in India.

Read more
19 Jan 2024 09:26

IN BRIEF: N4 Pharma gets India patent for medical delivery system

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - University of Queensland has informed the company that it has been notified by its Indian patent attorney of the granting of its patent for Nuvec in India. Nuvec is a novel silica nanoparticle delivery system for cancer treatments, gene therapy and vaccines. N4 Pharma says the granted patent in India is for a composition of matter patent for the particle itself, alongside the manufacturing process relating to how the particle is made. Says it matches the patents granted in the US, Canada, Europe, Japan, Australia and China.

Read more
16 Jan 2024 14:05

N4 Pharma subsidiary agrees work programme for glaucoma treatment

(Sharecast News) - N4 Pharma announced a significant development through its subsidiary Nanogenics on Tuesday, after Nanogenics inked a contract to initiate the formulation and sequence selection work for its ECP105 product, aimed at pre-clinical studies at King's College, London.

Read more
16 Jan 2024 13:26

IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec, a novel silica nanoparticle delivery system, for vaccines and therapeutics - Says subsidiary, Nanogenics Ltd, has signed a contract to start the formulation and sequence selection work to prepare its ECP105 product for testing in pre-clinical studies at King's College, London.

Read more
8 Jan 2024 12:30

N4 Pharma reports progress in Nuvec clinical research

(Sharecast News) - Pharmaceutical delivery system developer N4 Pharma reported significant progress in its research efforts to enhance viral vector performance using Nuvec on Monday.

Read more
8 Jan 2024 09:11

N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8

(Alliance News) - N4 Pharma PLC on Monday said that a series of experiments have shown that Nuvec can deliver increased transduction efficacy, when complexed with Adeno-Associated virus 8.

Read more
18 Dec 2023 16:55

LONDON MARKET CLOSE: FTSE 100 outperforms European peers

(Alliance News) - Stock prices in London closed higher on Monday, after investors shrugged off hawkish comments from US Federal Reserve officials amid festive cheer.

Read more
18 Dec 2023 12:43

N4 Pharma rises on successful results from Nuvec administration

(Alliance News) - N4 Pharma PLC on Monday announced the successful oral administration of Nuvec with a DNA plasmid after receiving promising results from its research programme with the University of Queensland.

Read more
18 Dec 2023 11:17

N4 Pharma upbeat on recent Nuvec developments

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.